Entry |
|
Name |
Toceranib (USAN) |
Formula |
C22H25FN4O2
|
Exact mass |
396.1962
|
Mol weight |
396.46
|
Structure |

|
Simcomp |
|
Class |
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
|
Remark |
|
Efficacy |
Antineoplastic (veterinary), Angiogenesis inhibitor, Receptor tyrosine kinase inhibitor |
Comment |
Treatment of mast cell tumors in dogs
|
Target |
|
Pathway |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
DG01363 Toceranib
D08503 Toceranib
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
PDGFR family
PDGFR
D08503 Toceranib (USAN)
KIT (CD117)
D08503 Toceranib (USAN)
VEGFR family
VEGFR2 (KDR)
D08503 Toceranib (USAN)
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
DG01363 Toceranib
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 29
1 C8x C 17.1500 -5.8800
2 C8x C 15.9600 -6.5800
3 C8y C 15.9600 -7.9800
4 C8x C 17.1500 -8.6800
5 C8y C 18.3400 -7.9800
6 C8y C 18.3400 -6.5800
7 C2y C 19.7400 -8.4000
8 C5x C 20.5100 -7.2800
9 N1x N 19.7400 -6.1600
10 X F 14.7700 -8.6800
11 O5x O 21.9100 -7.2800
12 C2b C 19.7400 -9.8000
13 C8y C 20.9300 -10.5000
14 C8y C 20.9300 -11.9000
15 C8y C 22.2600 -12.3200
16 C8y C 23.0300 -11.2000
17 N4x N 22.2600 -10.0800
18 C1a C 19.7400 -12.7400
19 C1a C 24.5000 -11.2000
20 C5a C 22.2600 -13.7900
21 O5a O 21.0700 -14.4900
22 N1b N 23.5200 -14.4900
23 C1b C 24.7100 -13.7900
24 C1b C 25.9000 -14.4900
25 N1y N 27.0900 -13.7900
26 C1x C 28.4247 -14.2127
27 C1x C 29.2391 -13.0740
28 C1x C 28.4078 -11.9475
29 C1x C 27.0796 -12.3900
BOND 32
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 1
10 6 9 1
11 3 10 1
12 8 11 2
13 7 12 2
14 12 13 1
15 13 14 2
16 14 15 1
17 15 16 2
18 16 17 1
19 13 17 1
20 14 18 1
21 16 19 1
22 15 20 1
23 20 21 2
24 20 22 1
25 22 23 1
26 23 24 1
27 24 25 1
28 25 26 1
29 26 27 1
30 27 28 1
31 28 29 1
32 25 29 1
|